Archive ready

カワニシホールディングス 2017年6月期第2四半期報告書

https://www.olba.co.jp/ir/upload_file/m004-m004_01/20170303report.pdf
May 13, 2026 at 02:55 PM JSTThe archive page, viewer, and downloads use this saved version.
May 13, 2026 at 02:55 PM JST·www.olba.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

カワニシホールディングス 2017年6月期第2四半期報告書

StartedMay 13, 2026 at 02:55 PM JST
File size0.35 MB
SHA-256c51cad28ac105cfc13cfe9728296ae68df99457a8071235bf4e7ce3910da7a1b
About this pageAI generated

This document summarizes the financial report for the second quarter of the fiscal year ending June 2017 for Kawanishi Holdings. The consolidated sales reached 53.184 billion yen, with operating profit at 571 million yen, ordinary profit at 590 million yen, and net profit at 377 million yen. Notably, sales of equipment in the Tohoku region increased significantly by 125% compared to the previous year. The medical equipment business accounts for over 90% of total sales. The company is also launching a new business for breath-based breast cancer screening and promoting collaboration in the medical field. The nursing care product business continues to grow, with plans to expand its operational base. Overall, there is a notable increase in sales and profits, indicating a positive growth strategy for the future.